Literature DB >> 9722532

Contribution of proline residue for efficient production of MHC class I ligands by proteasomes.

N Shimbara1, K Ogawa, Y Hidaka, H Nakajima, N Yamasaki, S Niwa, N Tanahashi, K Tanaka.   

Abstract

Proteasomes are processing enzymes capable of generating major histocompatibility complex (MHC) class I ligands, but the mechanism of how they excise ligands without destroying them is largely unknown. Previously, we reported that most products of ornithine decarboxylase degraded in vitro by the 26 S ATP-dependent proteasome, which contained one or two Pro residues (Tokunaga, F., Goto, T., Koide, T., Murakami, Y., Hayashi, S., Tamura, T., Tanaka, K., and Ichihara, A. (1994) J. Biol. Chem. 269,17382-17385), which implied that the Pro residue has a role in the escape from random cleavage by proteasomes. Here, we examine the role of the Pro residue in producing MHC class I ligands in vitro. Proteasomes generated two cytotoxic T lymphocyte-epitopic precursor peptides, SIIPGLPLSL and DMYPHFMPTNL, from the 29-mer and 25-mer peptides harboring these sequences, which are derived from the c-akt proto-oncogene and the pp89 protein of mouse cytomagalovirus, respectively. Replacement of the first or second Pro residue within these epitopes by Ala resulted in a marked reduction of this epitope-derived production or their random cleavage by proteasomes, irrespective of the presence of PA28, which greatly accelerates the generation of unmodified ligands. Moreover, replacement of a single amino acid residue other than Pro in both epitopic and flanking regions by Ala or Leu had no or little appreciable effect on the SIIPGLPLSL or its derivative production. Thus, Pro residue(s) within these epitopic sequences presumably contributes to efficient production of MHC class I ligands through prevention of their random cleavage by proteasomes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9722532     DOI: 10.1074/jbc.273.36.23062

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance.

Authors:  Stefan Tenzer; Edmund Wee; Anne Burgevin; Guillaume Stewart-Jones; Lone Friis; Kasper Lamberth; Chih-hao Chang; Mikkel Harndahl; Mirjana Weimershaus; Jan Gerstoft; Nadja Akkad; Paul Klenerman; Lars Fugger; E Yvonne Jones; Andrew J McMichael; Søren Buus; Hansjörg Schild; Peter van Endert; Astrid K N Iversen
Journal:  Nat Immunol       Date:  2009-05-03       Impact factor: 25.606

2.  Comparative vaccine studies in HLA-A2.1-transgenic mice reveal a clustered organization of epitopes presented in hepatitis C virus natural infection.

Authors:  Nourredine Himoudi; Jean-Daniel Abraham; Anne Fournillier; Yu Chun Lone; Aurélie Joubert; Anne Op De Beeck; Delphine Freida; François Lemonnier; Marie Paule Kieny; Geneviève Inchauspé
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.

Authors:  M Lucchiari-Hartz; P M van Endert; G Lauvau; R Maier; A Meyerhans; D Mann; K Eichmann; G Niedermann
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

4.  Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products.

Authors:  R E Toes; A K Nussbaum; S Degermann; M Schirle; N P Emmerich; M Kraft; C Laplace; A Zwinderman; T P Dick; J Müller; B Schönfisch; C Schmid; H J Fehling; S Stevanovic; H G Rammensee; H Schild
Journal:  J Exp Med       Date:  2001-07-02       Impact factor: 14.307

5.  Peptide presentation by bat MHC class I provides new insight into the antiviral immunity of bats.

Authors:  Dan Lu; Kefang Liu; Di Zhang; Can Yue; Qiong Lu; Hao Cheng; Liang Wang; Yan Chai; Jianxun Qi; Lin-Fa Wang; George F Gao; William J Liu
Journal:  PLoS Biol       Date:  2019-09-09       Impact factor: 8.029

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.